Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Dickinson KL, Patil SR, Pattanayak SK, Poulos C, Yang JH. Nature's call: impacts of sanitation choices in Orissa, India. Econ Dev Cult Change. 2015 Oct;64(1):1-29.
Herring WL, Herrmann JW. The single-day surgery scheduling problem: sequential decision-making and threshold-based heuristics. OR spectrum: quantitative approaches in management. 2012 Apr 1;34(2):429-59.